Pharma-Watch will keep you aware of
any possibly “infringing” generic products as soon they are launched in a certain country, hence, help with better enforcement of the registered patents of your originator products.
Upon requesting this service, a quarterly report will be delivered to your e-mail inbox, the report shall contain the following information: brand name,
generic name, dosage form, manufacturer name and marketing authorization
status. We offer this service in Saudi Arabia, Oman, Bahrain, Qatar, UAE and
Egypt.